Invex Therapeutics Limited ¦ ABN 29 632 145 334¦ Level 3, 101 St Georges Terrace, Perth WA 6000 ¦ ASX Announcement 25 September 2026 Date of AGM and Closing Date for Director Nominations In accordance with ASX Listing Rule 3.13.1, Invex Therapeutics Limited (ASX: IXC) (Company) advises that...
AGM Date and Closing Date for Director Nominations
Filed with ASX ·
6ix hasn’t read this filing yet.
Invex Therapeutics Ltd. on 6ix
Earlier from Invex Therapeutics
- Appendix 4G and Corporate Governance Statement
- Appendix 4E and Annual Report to shareholders
- Appendix 4D and Half Year Report
- Quarterly Activities/Appendix 4C Cash Flow Report
- Reinstatement to Quotation
Later from Invex Therapeutics
- Notice of Annual General Meeting/Proxy Form
- Trading Halt
- Invex to Acquire Rekover Therapeutics
- Proposed issue of securities - IXC
- Application for quotation of securities - IXC
Follow Invex Therapeutics into a list and get an email when it puts out news.
Follow Invex Therapeutics